Company intelligence / Profile preview

Medicines Development for Global Health

Melbourne/Southbank, Victoria, Australiamedicinesdevelopment.com ↗

Ownership: Private
Development stage: Commercial

Overview

MDGH achieved FDA approval in the US for moxidectin as a novel treatment for river blindness—the first new drug approved for this indication in over two decades. Moxidectin has since been rolled out in Ghana as part of mass drug administration efforts. The company’s pipeline includes additional indications such as scabies and whipworm, with positive Phase II results reported. Dovramilast was licensed from Amgen to advance development against tuberculosis and leprosy type II reactions; an IND has been submitted to the FDA.

Therapeutic areas: Infectious Diseases
Modalities: Small molecules (e.g., moxidectin, dovramilast)
Industry: Biotech

Drug pipeline

3 assets

moxidectin

Approved

2 more assets in the full pipeline.

Partnerships

Global Health Investment FundWHO/TDR Special ProgrammePhastar Cares pro bono support schemevarious academic/research institutions

Beyond the preview

Go deeper on Medicines Development for Global Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medicines Development for Global Health.